Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders

Relay Therapeutics reported early Phase 2 data showing lesion reduction and symptom improvement with zovegalisib.

Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law

Supreme Court lets Medicare drug price negotiations continue, rejecting pharma industry challenges to the Biden-era program.

4 Health Care Stocks With Whale Alerts In Today's Session

Trump's Drug Pricing Plan Gains Surprise Democratic Ally— Peter Welch Vows To 'Make It Happen'

Democrat Sen. Peter Welch backs Trump's MFN drug pricing plan as bipartisan pressure over prescription costs grows.

These Analysts Increase Their Forecasts On Arvinas After Q1 Results

Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Pharmaceuticals (NASDAQ:RIGL) announced global licensing agreement with Arvinas and Pfizer (NYSE:PFE) for oral PROTAC drug VEPPANU. Arvinas shares rose 1.7% on Wednesday and analysts have raised price targets.

Pfizer Receives European Commission Marketing Authorization To Expand The Approved Indication For HYMPVAZI To Include Patients 12 Years Of Age And Older Weighing At Least 35KG With Hemophilia

HYMPAVZI offers a combination of superior bleed protection compared to on-demand (OD) treatment that is well-tolerated with a straightforward, once-weekly subcutaneous injection administration that does not require

Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer

Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer following recent FDA approval.

Arvinas, Pfizer Strike Up To $405M VEPPANU Licensing Deal With Rigel

Arvinas, Inc. (NASDAQ:ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, and Pfizer Inc. (NYSE:PFE) have entered into a license agreement with Rigel Pharmaceuticals, Inc.,

Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb

Moderna and Novavax stocks climb as investors digest new cases in the hantavirus outbreak.

Trump Admin Proposes New IVF Benefit To Expand Fertility CoverageThrough Employers

Trump administration proposes new IVF benefits rule aimed at expanding employer fertility coverage and lowering treatment costs.